Actualité santé
Pluristem : unique competitive position in being the only company with the ability to manufacture mass quantities of cells in a three dimensional manner
29 Février 2012
Pluristem have been very busy during the last few quarters in exploiting our unique competitive position in being the only company with the ability to manufacture mass quantities of cells in a three dimensional manner. This advantage has attracted the attention of pharmaceutical companies in supporting our out-license business model for our PLacental eXpanded (PLX) cells. We have made... |